Business in Brief

Teva faces big new generic rival, thanks to former CEO Israel Makov.

Send in e-mailSend in e-mail
Outside the Tel Aviv Stock Exchange in Tel Aviv, Israel, August 13, 2013.Credit: Bloomberg

Comments